Outcome of Board Meeting held on 12th August, 2026 for the quarter ended on 30th June, 2026.

Symbiio x Investment & Tradii ng Co. Ltd. 221, Raabbinidrnad SraraSaarna nii,, 33r1ddF lF oor Room No. 1, Kolkata Contact : 98302 74227 CIN : L65993WB1979PLC032012 Website : www.symbioxinvestment.com E-mail : symbioxinvestment100@gmail.com Date: 12 August, 2026 To, To, Compliance Department The Calcutta Stock Exchange Limited Metropolitan Stock Exchange ofI ndia Limited 7, Lyons Range, Vibgyor Towers. 4th floor, Plot No C 62, G - Bloc Kolkata- 700 001 Opp. Trident Hotel, Bandra Kurla Complex, Bandra (E), Mumbai — 400 098 I'he Bombay Stock Exchange Limited, PJ Towers, Dalal Street Mumbai- 400 001 Subject: Outcome of 2" /2026-27 Board Meeting to be helodn 12" August, 2026. BSE Scrip Code: 539278 CSE Scrip Code: 029461 Symbol: SYMBIOX Dear Sir, We would like to inform you that the Meeting of Board of Directors of M/s. Symbiox Investment & Trading Co Ltd was held on 12 August, 2026 Wednesday at 02:30 P.M. at its r red office address to inter-alia transact the tollowing matters: 1. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, approved the Unaudited Financial Results for the quarter ended on 30" June, 2026. Adopted Auditor’s Limited Review Report given by Statutory Auditor oft he Company for the quarter ended on 30™ June, 2026. 3. No other matters was transacted at the meeting. Kindly note that the meeting of the Board of Directors commenced at 02:30 P.M and concluded at 04:00 P.M. Please take the same on your record and acknowledge the receipt of the same. I'hanking You. Yours Faithfully, For Symbiox Invest rading Co Ltd K. il Khushboo Pitti Company Secreta ‘Compliance Officer M. No. A25950 SYMBIOX INVESTMENT & TRADING CO LTD 221, RABINDRA SARANI, 3RD FLOOR, ROOM NO-1, KOLKATA -700007 CIN - L65993WB1979PLC032012 Email - symbioxinvestment100@gmail.com; Website: www. symbioxinvestment.com Satement of Unaudited Financial Result for the quarter ended 30th June, 2026 (Rupees in Lakh except EPS) . Quarter ended Year ended Particulars 30-06-2026 31-03-2026 30-06-2025 31-03-2026 - Unaudited Audited Unaudited | _Audited "1 |Revenue From Operations 2553 82.73 45.81 160.29 Il |Other Income 0.00 0.00 0.19. 0.23 i Total Income (I+11) 25.53 82.73 46.00 160.52 IV |[EXPENSES . Cost of materials consumed - - - 0.00 Purchases of Stock-in-Trade 0.00 0.00 9.48 33.67 Changes in inventories of finished goods, Stock-in -Trade and work-in-progress 0.00] 73.51 13.80; 66.25 . Employee benefits expense 6.04/ 5.08 4.07 20.47 Finance costs - - - 0.00 ] Depreciation and amortization expense 0.07 0.07 0.07 0.29 Other expenses 8.97 2.42 9.54 19.26 Total expenses (IV) 15.08] 81.08] 36.96. 139.94 Profit/(loss) before exceptional items and vV [tax (- 1v) 10.45 1.65 9.04 20.58 VI |Exceptional Items -| -| - 0.00 Profit/(loss) before tax VIE [(V-vI) 10.45 1.65 9.04 20.58 Vil |Tax expense (1) Current tax 2.72 0.43 2.35 5.35 (2) beferred tax -| - - 0.00 Profit (Loss) for the period from X |continuing operations (VII-VII) 7.73 1.22 6.69 15.23 X |Profit/(loss) from discontinued operations - - - 0.00 X |Tax expense of discontinued operations - - - 0.00! Profit/(loss) from Discontinued operations X |(after tax) (X-XI) 7.73 1.22 6.69 15.23 Xl |Profit/(loss) for the period (IX+XIl) 7.73 1.22) 6.69 15.23 XIV |Other Comprehensive Income A (i) Items that will not be reclassified to profit or loss - - - (ii) Income tax relating to items that will {not be reclassified to profit or loss - - - B (i) Items that will be reclassified to [profit or loss - - - R (i) Income tax relating to items that will be reclassified to profit or loss - - - - Total Comprehensive Income for the period (XI+XIV)(Comprising Profit (Loss) and Other Comprehensive Income ~XV_|for the period) - - -| - Paid up equity share Capital ( No. of Shares) 31287330 31287330 31287330 31287330, Face Value 10.00 10.00 10.00 10.00 Other Equity 58.90] Earnings per equity share (for continuing XVI |operation): (1) Basic 0.025 0.004 0.021 0.049 (2) Diluted 0.025 0.004 0.021 0.049 - Earnings per equity share (for discontinued XVII |operation): |y Basic 0.000 0.000 0.000 0.000 (2) Diluted 0.000 0.000] 0.000 0.000 Earnings per equity share(for discontinued XVl |& continuing operations) (1) Basic 0.025 0.004] 0.021 0.049 (2) Diluted 0.025 0.004] 0.021 0.049 1 |The above Unaudited financial results were reviewed by Audit Committee and approved by the Board of Directors lin their meeting held on 12/08/2026. 2 |The figures for the quarter on 30th June 2026 and 31 March 2026 are the balancing figures between audited figures of the full financial years ended on 31 March, 2026 . 3 |The Statutory auditors of the Company have carried out a "Auditor’s report" of the above results as per Regulation |32 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, The Company has adopted Indian Accounting standards (Ind AS) with effect trom 017 April, 2017 and accordingly, 4 |the above results have been prepared in accordance with the Companies (Indian Accounting Standard) Rules, 2015 prescribed under Section 133 of the Companies Act, 2013 ; The above results for the quarter ended 30th June, 2026 along with Auditor Report has been approved by the > |Board of Directors of the Company. The previous period figures have been regrouped wherever necessary. Ihere are no qualofication in the Audit Report issued by the Auditor For and behalf of Board SYMBIOX INVESTMENT & TRADING CQ Place: Kolkata SAMIT RAY™ Date: 12.08.2026 Managing Director DIN No. 08406285